Satomi Onoue

Author PubWeight™ 24.26‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int J Pharm 2011 1.38
2 Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomes. Drug Metab Pharmacokinet 2012 0.87
3 Structure-activity relationships of receptor binding of 1,4-dihydropyridine derivatives. Biol Pharm Bull 2008 0.86
4 Isolation and pharmacological characterization of fatty acids from saw palmetto extract. Anal Sci 2009 0.85
5 Liposomal formulations of glucagon-like peptide-1: improved bioavailability and anti-diabetic effect. Int J Pharm 2009 0.84
6 Physicochemical and pharmacokinetic characterization of water-soluble Coenzyme Q(10) formulations. Int J Pharm 2008 0.82
7 Development of rapid and simultaneous quantitative method for green tea catechins on the bioanalytical study using UPLC/ESI-MS. Biomed Chromatogr 2012 0.82
8 Novel crystalline solid dispersion of tranilast with high photostability and improved oral bioavailability. Eur J Pharm Sci 2009 0.81
9 In vitro and in vivo characterization of new formulations of St. John's Wort extract with improved pharmacokinetics and anti-nociceptive effect. Drug Metab Pharmacokinet 2011 0.81
10 Photoreactivity of amino acids: tryptophan-induced photochemical events via reactive oxygen species generation. Anal Sci 2007 0.79
11 Photosafety assessments on pirfenidone: photochemical, photobiological, and pharmacokinetic characterization. J Photochem Photobiol B 2013 0.79
12 Novel dry powder formulation of ovalbumin for development of COPD-like animal model: Physicochemical characterization and biomarker profiling in rats. Eur J Pharm Sci 2009 0.79
13 Development of micellar reactive oxygen species assay for photosafety evaluation of poorly water-soluble chemicals. Toxicol In Vitro 2013 0.79
14 Physicochemical and pharmacological characterization of alpha-tocopherol-loaded nano-emulsion system. Int J Pharm 2010 0.79
15 Erythritol-based dry powder of glucagon for pulmonary administration. Int J Pharm 2005 0.78
16 Inhalable powder formulation of a stabilized vasoactive intestinal peptide (VIP) derivative: anti-inflammatory effect in experimental asthmatic rats. Peptides 2009 0.78
17 Combined use of in vitro phototoxic assessments and cassette dosing pharmacokinetic study for phototoxicity characterization of fluoroquinolones. AAPS J 2011 0.78
18 Green tea extract affects the cytochrome P450 3A activity and pharmacokinetics of simvastatin in rats. Drug Metab Pharmacokinet 2013 0.78
19 High-throughput screening strategy for photogenotoxic potential of pharmaceutical substances using fluorescent intercalating dye. J Pharm Biomed Anal 2010 0.78
20 Crystalline form information from multiwell plate salt screening by use of Raman microscopy. Pharm Res 2006 0.78
21 Pituitary adenylate cyclase-activating polypeptide (PACAP)-like immunoreactivity in the brain of a teleost, Uranoscopus japonicus: immunohistochemical relationship between PACAP and adenohypophysial hormones. Regul Pept 2005 0.77
22 Comparative studies on physicochemical stability of cyclosporine A-loaded amorphous solid dispersions. Int J Pharm 2012 0.77
23 Electrophoretic analysis of proteins and enantiomers using capillaries modified by a successive multiple ionic-polymer layer (SMIL) coating technique. Anal Bioanal Chem 2006 0.77
24 Novel vasoactive intestinal peptide derivatives with improved stability protect rat alveolar L2 cells from cigarette smoke-induced cytotoxicity and apoptosis. Peptides 2010 0.77
25 Overview of green tea interaction with cardiovascular drugs. Curr Pharm Des 2015 0.77
26 In vitro/in vivo phototoxic risk assessments of griseofulvin based on photobiochemical and pharmacokinetic behaviors. Eur J Pharm Sci 2009 0.77
27 Muscarinic Receptor Binding in Rat Bladder Urothelium and Detrusor Muscle by Intravesical Solifenacin. Biol Pharm Bull 2016 0.77
28 Development of dry powder inhalation system of novel vasoactive intestinal peptide (VIP) analogue for pulmonary administration. Life Sci 2006 0.76
29 Pharmacological effects and lung-binding characteristics of a novel VIP analogue, [R15, 20, 21, L17]-VIP-GRR (IK312532). Regul Pept 2004 0.76
30 Respirable dry powder formulation of bleomycin for developing a pulmonary fibrosis animal model. J Pharm Sci 2012 0.76
31 Development of meloxicam salts with improved dissolution and pharmacokinetic behaviors in rats with impaired gastric motility. Pharm Res 2012 0.76
32 Pharmacological effects of saw palmetto extract in the lower urinary tract. Acta Pharmacol Sin 2009 0.75
33 New dipyridamole salt with improved dissolution and oral bioavailability under hypochlorhydric conditions. Drug Metab Pharmacokinet 2013 0.75
34 Pirfenidone in respirable powder form for the treatment of pulmonary fibrosis: a safer alternative to the current oral delivery system? Ther Deliv 2013 0.75
35 In vitro photobiochemical characterization of sulfobutylether-β-cyclodextrin formulation of bufexamac. J Pharm Biomed Anal 2011 0.75
36 Novel formulations of dipyridamole with microenvironmental pH-modifiers for improved dissolution and bioavailability under hypochlorhydria. Int J Pharm 2012 0.75
37 Solid form selection of zwitterionic 5-HT4 receptor agonist. Int J Pharm 2007 0.75
38 Evaluation of hydrate formation of a pharmaceutical solid by using diffuse reflectance infrared Fourier-transform spectroscopy. J Pharm Biomed Anal 2007 0.75
39 Up-regulation of nicotinic and muscarinic receptor mRNA in rat bladder by repeated administration of nicotine in relation to the pharmacokinetics. Life Sci 2011 0.75
40 Exploratory and regulatory assessments on photosafety of new drug entities. Curr Drug Saf 2012 0.75
41 Fundamental studies on electrokinetic chromatography with PEGylated phospholipid micelles. Anal Sci 2008 0.75
42 Microenvironmental pH-modification to improve dissolution behavior and oral absorption for drugs with pH-dependent solubility. Expert Opin Drug Deliv 2014 0.75
43 A newly developed enzyme-immunoassay for measuring the tissue contents of PACAP in fish. Peptides 2002 0.75
44 Stable dry powder inhaler formulation of tranilast attenuated antigen-evoked airway inflammation in rats. Eur J Pharm Biopharm 2010 0.75
45 Regional concentration and chromatographic characterization of pituitary adenylate cyclase-activating polypeptide (PACAP) in the brain of the bullfrog, Rana catesbeiana. Zoolog Sci 2003 0.75
46 Physicochemical stability study on cyclosporine A loaded dry-emulsion formulation with enhanced solubility. Chem Pharm Bull (Tokyo) 2015 0.75
47 Development of cyclosporine A-loaded dry-emulsion formulation using highly purified glycerol monooleate for safe inhalation therapy. Int J Pharm 2013 0.75
48 Effect of spectroscopic properties on photostability of tamoxifen citrate polymorphs. Int J Pharm 2006 0.75